Perceptive Capital Solutions Corp (PCSC) Financial Statements (2026 and earlier)

Company Profile

Business Address 51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments865,0311,177,9091,344,4091,191,9371,129,6841,209,453
Cash and cash equivalent865,0311,177,9091,344,4091,191,9371,129,6841,209,453
Prepaid expense42,53985,213121,470151,556115,006160,331
Total current assets:907,5701,263,1221,465,8791,343,4931,244,6901,369,784
Noncurrent Assets
Asset, held-in-trust91,872,41890,937,74789,936,95389,288,91088,654,39787,637,039
Total noncurrent assets:91,872,41890,937,74789,936,95389,288,91088,654,39787,637,039
TOTAL ASSETS:92,779,98892,200,86991,402,83290,632,40389,899,08789,006,823
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,254,244934,557281,154265,572210,811159,979
Accrued liabilities2,254,244934,557281,154265,572210,811159,979
Total current liabilities:2,254,244934,557281,154265,572210,811159,979
Noncurrent Liabilities
Other undisclosed noncurrent liabilities3,450,0003,450,0003,450,0003,450,0003,450,0003,450,000
Total noncurrent liabilities:3,450,0003,450,0003,450,0003,450,0003,450,0003,450,000
Total liabilities:5,704,2444,384,5573,731,1543,715,5723,660,8113,609,979
Temporary equity, including noncontrolling interest91,872,41890,937,74789,936,95389,288,91088,354,39787,337,039
Equity
Equity, attributable to parent, including:(4,796,674)(3,121,435)(2,265,275)(2,372,079)(2,116,121)(1,940,195)
Accumulated deficit(4,796,919)(3,121,680)(2,265,520)(2,372,324)(2,116,366)(1,940,440)
Other undisclosed equity, attributable to parent245245245245245245
Total equity:(4,796,674)(3,121,435)(2,265,275)(2,372,079)(2,116,121)(1,940,195)
TOTAL LIABILITIES AND EQUITY:92,779,98892,200,86991,402,83290,632,40389,899,08789,006,823

Income Statement (P&L) (USD)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Operating expenses(1,675,239)(856,160)(193,196)(255,958) (196,128)
Operating loss:(1,675,239)(856,160)(193,196)(255,958) (196,128)
Nonoperating income934,6711,000,794948,043934,513 1,177,610
Investment income, nonoperating 1,000,794948,043934,513 1,177,610
Net income (loss) available to common stockholders, diluted:(740,568)144,634754,847678,555 981,482

Comprehensive Income (USD)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net income (loss):(740,568)144,634754,847678,555 981,482
Comprehensive income (loss), net of tax, attributable to parent:(740,568)144,634754,847678,555 981,482

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: